- Anterix (ATEX) has surged 380% over the past year, recently hitting an all-time high of $113.
- ATEX maintains strong technical momentum with a 100% “Buy” rating from Barchart.
- Revenue is forecast to grow 220.2% this year and 33.7% next year, supporting continued bullish sentiment.
- Valuation concerns persist, with Seeking Alpha and Morningstar viewing ATEX as fairly valued or potentially overvalued despite strong growth.